IN2009CN03372A - - Google Patents
Download PDFInfo
- Publication number
- IN2009CN03372A IN2009CN03372A IN3372CHN2009A IN2009CN03372A IN 2009CN03372 A IN2009CN03372 A IN 2009CN03372A IN 3372CHN2009 A IN3372CHN2009 A IN 3372CHN2009A IN 2009CN03372 A IN2009CN03372 A IN 2009CN03372A
- Authority
- IN
- India
- Prior art keywords
- protein
- canine
- tslp
- peptide fragments
- canine tslp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
- C07K14/43—Sweetening agents, e.g. thaumatin, monellin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5418—IL-7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
- C07K16/464—Igs containing CDR-residues from one specie grafted between FR-residues from another
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5418—IL-7
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
- G01N2800/202—Dermatitis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87513506P | 2006-12-14 | 2006-12-14 | |
PCT/US2007/025318 WO2008076255A2 (en) | 2006-12-14 | 2007-12-11 | Canine thymic stromal lymphopoietin protein and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2009CN03372A true IN2009CN03372A (xx) | 2015-08-07 |
Family
ID=39430681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3372CHN2009 IN2009CN03372A (xx) | 2006-12-14 | 2007-12-11 |
Country Status (18)
Country | Link |
---|---|
US (3) | US7718772B2 (xx) |
EP (1) | EP2104683B1 (xx) |
JP (4) | JP2010512744A (xx) |
KR (1) | KR101525631B1 (xx) |
CN (2) | CN101631800B (xx) |
AU (1) | AU2007334531B2 (xx) |
BR (1) | BRPI0720001A2 (xx) |
CA (1) | CA2671865C (xx) |
CO (1) | CO6210756A2 (xx) |
ES (1) | ES2582655T3 (xx) |
IL (2) | IL199170A (xx) |
IN (1) | IN2009CN03372A (xx) |
MX (1) | MX2009006470A (xx) |
NZ (1) | NZ578352A (xx) |
RU (2) | RU2457217C2 (xx) |
UA (3) | UA95329C2 (xx) |
WO (1) | WO2008076255A2 (xx) |
ZA (1) | ZA200904152B (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0720001A2 (pt) | 2006-12-14 | 2013-12-24 | Schering Plough Ltd | Proteína linfopoietin estromal tímica canina e usos da mesma |
JP5492158B2 (ja) | 2011-08-24 | 2014-05-14 | 富士フイルム株式会社 | ヒトtsh及び犬tshに対する抗体 |
WO2013119419A1 (en) | 2012-02-08 | 2013-08-15 | North Carolina State University | Treatment of allergic diseases with recombinant antibodies |
AR090915A1 (es) * | 2012-05-04 | 2014-12-17 | Intervet Int Bv | Proteina de fusion de proteina linfopoyetina estromal timica canina con la region fc de igg |
EP2981280A2 (en) * | 2013-04-04 | 2016-02-10 | IEO - Istituto Europeo di Oncologia Srl | Thymic stromal lymphopoietin fragments and uses thereof |
MY177098A (en) * | 2013-08-09 | 2020-09-05 | Astellas Pharma Inc | Novel anti-human tslp receptor antibody |
CN105829344B (zh) | 2013-12-20 | 2021-12-07 | 英特维特国际股份有限公司 | 犬化鼠抗犬pd-1抗体 |
WO2015118124A1 (en) * | 2014-02-06 | 2015-08-13 | Vib Vzw | Thymic stromal lymphopoietin receptor antagonist |
JP6938383B2 (ja) | 2015-04-02 | 2021-09-22 | インターベット インターナショナル ベー. フェー. | イヌインターロイキン4受容体アルファに対する抗体 |
US10000561B2 (en) | 2015-09-09 | 2018-06-19 | Novartis Ag | Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules |
LT3347377T (lt) | 2015-09-09 | 2021-05-25 | Novartis Ag | Užkrūčio liaukos stromos limfopoetiną (tslp) rišantys antikūnai ir antikūnų panaudojimo būdai |
US11091556B2 (en) | 2015-12-18 | 2021-08-17 | Intervet Inc. | Caninized human antibodies to human IL-4R alpha |
JP7127859B2 (ja) | 2016-11-09 | 2022-08-30 | ノース カロライナ ステート ユニバーシティ | キメラタンパク質を用いたアレルギー疾患の治療 |
CN115028722A (zh) * | 2021-03-05 | 2022-09-09 | 拜西欧斯(北京)生物技术有限公司 | 抗tslp抗体及其制备方法和用途 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4281061A (en) | 1979-07-27 | 1981-07-28 | Syva Company | Double antibody for enhanced sensitivity in immunoassay |
US5714585A (en) | 1987-10-26 | 1998-02-03 | Sterling Winthrop, Inc. | Antibodies that are immunoreactive with interleukin-7 |
ZA887773B (en) | 1987-10-26 | 1989-07-26 | Immunex Corp | Interleukin-7 |
US5413914A (en) | 1993-07-07 | 1995-05-09 | The Regents Of The University Of Colorado | Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases |
US6844170B1 (en) | 1998-03-19 | 2005-01-18 | Human Genome Sciences, Inc. | Cytokine receptor common gamma chain like |
US20030099947A1 (en) | 1998-09-21 | 2003-05-29 | Bazan J. Fernando | Mammalian cytokines; related reagents and methods |
DE69936105T3 (de) | 1998-11-13 | 2017-07-27 | Immunex Corporation | Menschliche tslp nukleinsäuren und polypeptide |
AU2396600A (en) | 1998-12-30 | 2000-07-31 | Millennium Pharmaceuticals, Inc. | Secreted proteins and uses thereof |
GB9908533D0 (en) * | 1999-04-14 | 1999-06-09 | Novartis Ag | Organic compounds |
PT2077279E (pt) | 2000-06-28 | 2012-09-14 | Amgen Inc | Moléculas do receptor de linfopoietina estromal tímica e suas utilizações |
US6890734B2 (en) | 2000-11-10 | 2005-05-10 | Schering Corporation | Nucleic acids encoding a cytokine receptor complex |
DE602004016522D1 (de) * | 2003-07-18 | 2008-10-23 | Schering Corp | Behandlung und diagnose von neoplasien mit tslp (thymic stromal lymphopoietin) |
CA2575721A1 (en) * | 2004-07-28 | 2006-03-02 | Tanox, Inc. | Thymic stromal lymphopoietin promoter and uses therefor |
SE532251C2 (sv) * | 2006-11-28 | 2009-11-24 | Theravac Pharmaceuticals Ab | Nya formuleringar av TSLP för behandling av TH2-medierade inflammatoriska sjukdomar genom vaccinering |
BRPI0720001A2 (pt) | 2006-12-14 | 2013-12-24 | Schering Plough Ltd | Proteína linfopoietin estromal tímica canina e usos da mesma |
-
2007
- 2007-12-11 BR BRPI0720001-3A2A patent/BRPI0720001A2/pt not_active Application Discontinuation
- 2007-12-11 UA UAA200907400A patent/UA95329C2/ru unknown
- 2007-12-11 UA UAA201412004A patent/UA120027C2/uk unknown
- 2007-12-11 UA UAA201103603A patent/UA108064C2/uk unknown
- 2007-12-11 CN CN2007800512690A patent/CN101631800B/zh active Active
- 2007-12-11 IN IN3372CHN2009 patent/IN2009CN03372A/en unknown
- 2007-12-11 AU AU2007334531A patent/AU2007334531B2/en active Active
- 2007-12-11 RU RU2009126617/10A patent/RU2457217C2/ru active
- 2007-12-11 MX MX2009006470A patent/MX2009006470A/es active IP Right Grant
- 2007-12-11 KR KR1020097014362A patent/KR101525631B1/ko active IP Right Grant
- 2007-12-11 EP EP07867705.1A patent/EP2104683B1/en active Active
- 2007-12-11 CA CA2671865A patent/CA2671865C/en active Active
- 2007-12-11 CN CN201210044325.0A patent/CN102584998B/zh active Active
- 2007-12-11 WO PCT/US2007/025318 patent/WO2008076255A2/en active Application Filing
- 2007-12-11 JP JP2009541349A patent/JP2010512744A/ja active Pending
- 2007-12-11 NZ NZ578352A patent/NZ578352A/en not_active IP Right Cessation
- 2007-12-11 US US11/954,143 patent/US7718772B2/en active Active
- 2007-12-11 ES ES07867705.1T patent/ES2582655T3/es active Active
-
2009
- 2009-06-04 IL IL199170A patent/IL199170A/en not_active IP Right Cessation
- 2009-06-12 ZA ZA2009/04152A patent/ZA200904152B/en unknown
- 2009-06-16 CO CO09062338A patent/CO6210756A2/es not_active Application Discontinuation
-
2010
- 2010-03-10 US US12/721,002 patent/US8076456B2/en active Active
-
2011
- 2011-10-03 IL IL215507A patent/IL215507A0/en unknown
- 2011-11-11 US US13/294,680 patent/US8791242B2/en active Active
-
2012
- 2012-02-14 JP JP2012029831A patent/JP2012090647A/ja active Pending
- 2012-04-05 RU RU2012113162A patent/RU2617957C2/ru active
- 2012-11-30 JP JP2012262329A patent/JP5707380B2/ja active Active
-
2014
- 2014-12-26 JP JP2014265708A patent/JP6117767B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2009CN03372A (xx) | ||
PH12017501025A1 (en) | Antigen binding proteins capable of binding thymic stromal lymphopoietin | |
MX2009012812A (es) | Proteinas estructurales de una mutacion del parvovirus como vacunas. | |
WO2011032161A3 (en) | Vaccines directed to langerhans cells | |
MY162752A (en) | Alpha-4-beta-7 heterodimer specific antagonist antibody | |
WO2010104747A3 (en) | Antigen presenting cell targeted vaccines | |
WO2005120565A8 (en) | Sars vaccines and methods to produce highly potent antibodies | |
MX348154B (es) | Anticuerpos de enlace a il-1-beta y fragmentos de los mismos. | |
WO2005066204A3 (en) | Neutralizing epitope-based growth enhancing vaccine | |
WO2007098201A3 (en) | Shiga toxoid chimeric proteins | |
WO2010104761A3 (en) | Anti-cd40 antibodies and uses thereof | |
NZ600584A (en) | Anti-il 17a/il-17f cross-reactive antibodies and methods of use thereof | |
CU20120095A7 (es) | Antagonistas de pcsk9 | |
WO2008005880A3 (en) | Antibodies for norovirus | |
WO2006124451A3 (en) | Anti-il-13 antibodies, compositions, methods and uses | |
WO2008098917A3 (en) | Novel antibodies against igf-ir | |
MX2009013824A (es) | Proteinas de enlace de antigeno que enlazan par-2. | |
HK1113393A1 (en) | Secretion of antibodies without signal peptides from bacteria | |
MX2010001237A (es) | Nuevos anticuerpos. | |
WO2008118487A3 (en) | Compositions and methods for incresing immunogenicity of glycoprotein vaccines | |
ATE519784T1 (de) | An den humanen igg-fc-rezeptor iib (fcgammariib) bindende substanz | |
WO2007020520A3 (en) | Antigenic peptides and their use | |
AU2005292852A8 (en) | Method of immunizing animal, composition for immunization, method of producing antibody, method of producing hybridoma and method of producing monoclonal antibody | |
WO2007127372A3 (en) | Genetic adjuvants for viral vaccines | |
DE602005010680D1 (de) | Zusammensetzungen und verfahren zur induktion einer antitumorimmunität |